About Pear Therapeutics
Pear Therapeutics is a company based in Boston (United States) founded in 2013 by William Greene, Stephen Kennedy Smith, Ian Mcfarland, and Corey McCann. It operates as a B2B. Pear Therapeutics has raised $266.34 million across 9 funding rounds from investors including Novartis, HHS and Temasek. The company has 207 employees as of December 31, 2022. Pear Therapeutics has completed 1 acquisition, including Firsthand Technology. Pear Therapeutics operates in a competitive market with competitors including DarioHealth, Welldoc, Wellthy Therapeutics, Spiras Health and Ciba Health, among others.
- Headquarter Boston, United States
- Employees 207 as on 31 Dec, 2022
- Founders William Greene, Stephen Kennedy Smith, Ian Mcfarland, Corey McCann
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
$12.7 M0as on Dec 31, 2022
-
Net Profit
-
EBITDA
-
Total Equity Funding
$266.34 M (USD)
in 9 rounds
-
Latest Funding Round
-
Investors
Novartis
& 14 more
-
Employee Count
207
as on Dec 31, 2022
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Funding Insights of Pear Therapeutics
Pear Therapeutics has successfully raised a total of $266.34M across 9 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 9
- Last Round Last Round
- First Round First Round
- Investors Count 15
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2021 | Amount | Post-IPO - Pear Therapeutics | Valuation |
investors |
|
| Dec, 2020 | Amount | Series D - Pear Therapeutics | Valuation | SoftBank Vision Fund | |
| Jul, 2020 | Amount | Debt – Conventional - Pear Therapeutics | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Pear Therapeutics
Pear Therapeutics has secured backing from 15 investors, including venture fund and institutional investors. Prominent investors backing the company include Novartis, HHS and Temasek. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments in technology and startups.
|
Founded Year | Domain | Location | |
|
An investment platform is provided for diverse sectors and geographies.
|
Founded Year | Domain | Location | |
|
Healthcare venture capital investments are made by Arboretum Ventures.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Pear Therapeutics
Pear Therapeutics has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Firsthand Technology. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Virtual Reality Games, Simulations & Therapy
|
1995 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Pear Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Pear Therapeutics Comparisons
Competitors of Pear Therapeutics
Pear Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as DarioHealth, Welldoc, Wellthy Therapeutics, Spiras Health and Ciba Health, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Chronic conditions are managed via a personalized digital platform.
|
|
| domain | founded_year | HQ Location |
Mobile health products for chronic disease management are offered.
|
|
| domain | founded_year | HQ Location |
Health monitoring app is provided for chronic patients and providers.
|
|
| domain | founded_year | HQ Location |
Asthma and COPD symptoms are managed through clinical services.
|
|
| domain | founded_year | HQ Location |
Provider of teleconsultation and digital therapeutic software for employees and patients
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Pear Therapeutics
Frequently Asked Questions about Pear Therapeutics
When was Pear Therapeutics founded?
Pear Therapeutics was founded in 2013 and raised its 1st funding round 2 years after it was founded.
Where is Pear Therapeutics located?
Pear Therapeutics is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Who is the current CEO of Pear Therapeutics?
Corey McCann is the current CEO of Pear Therapeutics. They have also founded this company.
Is Pear Therapeutics a funded company?
Pear Therapeutics is a funded company, having raised a total of $266.34M across 9 funding rounds to date.
How many employees does Pear Therapeutics have?
As of Dec 31, 2022, the latest employee count at Pear Therapeutics is 207.
What is the annual revenue of Pear Therapeutics?
Annual revenue of Pear Therapeutics is $12.7M as on Dec 31, 2022.
What does Pear Therapeutics do?
Pear Therapeutics operates with a B2B model, focusing on providing healthcare solutions, providing digital health services, therapeutics, and chronic disease management. Pear Therapeutics provides cloud-based digital solutions for managing chronic health conditions effectively. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.
Who are the top competitors of Pear Therapeutics?
Pear Therapeutics's top competitors include Welldoc, Wellthy Therapeutics and DarioHealth.
How many acquisitions has Pear Therapeutics made?
Pear Therapeutics has made 1 acquisition, including Firsthand Technology.
Who are Pear Therapeutics's investors?
Pear Therapeutics has 15 investors. Key investors include Novartis, HHS, Temasek, SoftBank Vision Fund, and Perceptive Advisors.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.